Genetic and nutritional factors interact together and modulate the plasma lipid profile. We identified variations in the gene encoding the liver X receptor a (LXRa) and investigated their effects on the plasma lipoprotein/lipid profile. We also examined whether the association between cholesterol intake and plasma lipid profile was modulated by LXRa variants. The LXRa gene was sequenced in thirty-five French-Canadian men with high plasma total cholesterol (.5·0 mmol/l) and LDL-cholesterol (.3·5 mmol/l) concentrations. Dietary cholesterol was obtained from a food-frequency questionnaire. The LXRa c.-115G . A, c.-840C . A and c.-1830T . C genotypes were determined by direct sequencing in 732 subjects. Molecular screening of the LXRa gene revealed sixteen variants. Genotypes c.-115G . A, c.-840C . A and c.-1830T . C (rare allele frequency of 14·3 %, 14·2 % and 11·0 %, respectively) were analysed further. Plasma total cholesterol concentrations were higher in carriers of the -115A, -840A and -1830C allele, compared with the -115G/G, -840C/C and -1830T/T homozygotes (P#0·05). In a model including the c.-115G . A polymorphism, cholesterol intake, the interaction term c.-115G . A £ cholesterol intake (mg/d) and covariates, LXRa-115G . A explained 1·8 % and 2·1 % of the variance in total cholesterol and LDL-cholesterol concentrations (P¼0·02 and P¼ 0·01), whereas the interaction term explained 2·9 % (P¼0·002) and 2·8 % (P¼ 0·005), respectively. When subjects were divided into four groups according to the median of cholesterol (290·8 mg) and -115G . A genotypes, high cholesterol intake was associated with higher cholesterol levels in -115A carriers. Similar results were observed for c.-840C . A and c.-1830T . C. These results suggest that cholesterol intake interacts with LXRa variants to modulate the plasma lipid profile. Liver X receptor-a: Gene -diet interactions: Plasma lipoprotein/lipid profile: Cardiovascular disease: Dietary cholesterol intake * Corresponding author: Dr Marie-Claude Vohl, fax þ1 418 654 2145, email Marie-Claude.Vohl@crchul.ulaval.ca Abbreviations: LXRa, liver X receptor-a.
CVD is the leading cause of death in North America (Novak, 1998; Heart and Stroke Foundation of Canada, 2003) , emphasizing the need to understand its aetiology and to improve prevention and treatment strategies. Elevated plasma cholesterol concentrations are a well-known risk factor (Wilson et al. 1980; Grundy, 1995) . The importance of dietary cholesterol in determining plasma cholesterol concentrations has been well documented (Dayton et al. 1968; Turpeinen, 1979; Clarke et al. 1997; Hopkins, 1992) . There exists, however, a large interindividual variability in the plasma cholesterol response to changes in dietary cholesterol intake (Dreon & Krauss, 1997; Grundy & Denke, 1990) . Jacobs et al. (1983) have previously demonstrated that 9 % of subjects could be characterized as 'hyperresponders' when referring to the effect of a change in diet on plasma cholesterol levels, whereas 9 % were characterized as 'hyporesponders'. Scientific evidence suggests that genetic factors might explain some of the interindividual variability in the plasma cholesterol response following modifications in cholesterol intake (Ordovas & Schaefer, 1999) .
The liver X receptor a (LXRa) is a transcription factor expressed predominantly in the liver but also in the kidney, intestine, macrophages, adipose tissue, spleen and adrenal glands (Kohro et al. 2000) . LXRa regulates the expression of target genes by binding DNA sequence elements, termed LXR response elements (Willy et al. 1995) . Several genes encoding proteins involved in cholesterol metabolism, for example SREBP-1, ABCA1, ABCG5 and ABCG8, are regulated by LXRa (Peet et al. 1998 ). In addition, oxysterols, which are important in steroid hormone biosynthesis, bile acid synthesis and the conversion of lanosterol to cholesterol, are also potent activators of LXRa, suggesting that LXRa may be an important sensor of cholesterol metabolites (Janowski et al. 1996; Lehmann et al. 1997) and might be involved in the interindividual variability observed in the plasma cholesterol response to changes in dietary cholesterol intake.
The first aim of the present study was first to identify genetic variants in the LXRa gene and evaluate their effects on the plasma lipoprotein/lipid profile. Second, we examined whether polymorphisms in the LXRa gene could modulate the association between cholesterol intake and plasma lipoprotein/lipid profile.
Subjects and methods

Subjects
The study sample originates from the Saguenay-Lac-St-Jean region, located in the north-eastern part of the province of Quebec. A total of 732 subjects (614 men, 118 women) were recruited through the Chicoutimi Hospital Lipid Clinic. Subjects were excluded if they were diagnosed with type 2 diabetes, type III dysbetalipoproteinaemia, familial hypercholesterolaemia or familial combined hyperlipidaemia. Type 2 diabetes was diagnosed according to the WHO criteria (Alberti & Zimmet, 1998) . Written informed consent was obtained from all participating subjects, and the Medical Ethics Committee of Laval University and Chicoutimi Hospital Lipid Clinic approved the protocol.
Metabolic and anthropometric variables
Blood samples from subjects free of medication were obtained in the morning after a 12 h overnight fast. Blood was taken from an antecubital vein into vacutainer tubes containing EDTA. Blood samples were centrifuged within 1 h, and the plasma was frozen (2 808C) until analysis. Plasma cholesterol and triacylglycerol were measured using enzymatic assays (Burstein & Samaille, 1960; McNamara & Schaefer, 1987) . LDL-cholesterol was calculated using the Friedewald formula (Friedewald et al. 1972) . The HDL-cholesterol fraction was obtained after precipitation of LDL particles in the infranatant with heparin and MnCl 2 (Burstein & Samaille, 1960; Havel et al. 1955) . Apo B concentrations were measured in plasma by the rocket immunoelectrophoretic method of Laurell (1966) , as previously described (Moorjani et al. 1987) . Serum standards were prepared and calibrated against reference sera obtained from the Center for Disease Control (Atlanta, GA, USA). Body weight, height and BMI were recorded.
DNA analysis
Genomic DNA was extracted using the Qiagen extraction kit (San Francisco, USA). The exons, the exon-intron splicing boundaries as well as the 5 0 and 3 0 regions of the human LXRa gene were sequenced to screen for DNA variants in thirty-five men exhibiting high plasma total-cholesterol and LDL-cholesterol concentrations (.5 and . 3·5 mmol/l, respectively). Table 1 shows the primers used to amplify the different parts of the gene. Primers were designed using sequences available on GenBank (Accession numbers: AC024045) and Primer 3.0 software available on the Whitehead Institute/MIT Center for Genome Research server (Rozen & Skaletsky, 2000) . PCR conditions were as follows: reaction volume 50 ml, 1 U RedTaq DNA polymerase (Sigma; St Louis, MO, USA), 5 ml 10 £ PCR buffer recommended by the manufacturer, 1·5 mM-MgCl 2 , 0·2 mM-dNTP, 8·4 ml of each primer at a final concentration of 7·5 mM, 0·1 mg genomic DNA. Betaine was added for sequencing promoter fragments 4, 3 and 1, and exon 4. The annealing temperature for each fragment is shown in Table 1 .
Sequencing reactions were performed using BigDyeTerminator v3.0 cycle sequencing (ABI Prism; Applied Biosystems, Foster City, CA, USA) and the products were analysed on ABI 3100 automated DNA sequencer (PE Applied Biosystems). The gel files were processed using the ABI Prism3100 data collection software Applied Biosystems version 1.1 and ABI Prism DNA sequencing analysis software (PE Applied Biosystems) and then assembled and analysed using STADEN preGap4 and Gap4 software (http://staden.sourceforge.net/ staden_home.html). Newly identified single nucleotide polymorphisms were genotyped using the same primers and same methods as for sequencing.
Nutritional assessment
A quantitative food-frequency questionnaire was used to evaluate dietary cholesterol intake and was available for 337 subjects. A trained dietitian administered this forty-eightitem questionnaire to participants. The dietitian asked the subjects to recall average use over the previous year. The frequency of food consumption was based on the number of times items were consumed per day, per week or per month. Nutrition Data System for Research version 4.02 (developed by the Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN, USA; Food and Nutrient Database 30, published in November 1999) was used to calculate nutrients. The food-frequency questionnaire has been validated, in twenty-five men and women within the same population, using a 3 d food record (V Provencher et al. unpublished results). Furthermore, dietary cholesterol intake from food-frequency questionnaires correlated significantly with cholesterol intake as assessed by 3 d food records (r ¼ 0·75, P¼0·0001).
Statistical analyses
Variables not normally distributed (triacylglycerol, fasting insulin, cholesterol and total-cholesterol:HDL-cholesterol ratio) were log 10 transformed. To establish possible linkage disequilibrium between two polymorphisms, we used the software programs EH and 2LD (Linkage Utility Programs, Rockefeller University, USA: Mathematics & Statistics on the WWW). The Bayesian statistical method implemented in the program PHASE (version 2.1) was used to estimate haplotype frequencies in this study sample (Stephens et al. 2001) . The association between polymorphisms in the LXRa gene and the plasma lipoprotein/lipid profile was evaluated by analyses of covariance with confounding variables (age and sex or age, sex and BMI) included in the model. Partial Pearson correlation coefficients were used to quantify the age-adjusted interrelationships between the plasma lipoprotein/lipid profile and dietary cholesterol intake in the entire cohort as well as within each genotype group. Gene-diet interactions were evaluated by analyses of covariance using general linear model procedures. Included in the model were the LXRa polymorphism, cholesterol intake, the interaction term and confounding variables (age, gender, energy intake). The source of variation in metabolic parameters was computed using the type III sum of squares. This sum of squares applies to unbalanced study designs and quantifies the effects of an independent variable after adjusting for all other variables included in the model. All the analyses were performed with SAS version 8.2 (SAS Institute, Cary, NC, USA). A value of P# 0·05 was used to identify a statistically significant result.
Results
Molecular screening of the LXRa gene revealed the presence of sixteen polymorphisms ( Fig. 1(A) ), located principally in the 5 0 and intronic regions. One single nucleotide polymorphism was located in exon 5, but it did not alter the predicted serine for this gene at position 99 (c.297C . T or p.Ser99Ser). The relative allele frequency of these variants is shown in Table 2 . Database analysis of sequences containing these polymorphisms revealed potential binding sites for the transcription factors Sp-1, HES-1, USF and GATA-1 on the common -115G, -840C and -1830T alleles ( Fig. 1(B) ; using Transcription Element Search Software; http://www.cbil.upenn.edu.tess). The likely functional polymorphisms -115G . A, -840C . A and -1830T . C were therefore selected for further analysis. The genotype distribution of each genetic variant was in Hardy -Weinberg equilibrium. We also observed that these polymorphisms were in perfect linkage disequilibrium (D 0 ¼ 1·0, P,0·0001 for each pair of single nucleotide polymorphism). Haplotypes were further inferred using PHASE software. Owing to complete linkage disequilibrium between each pair of single nucleotide polymorphisms, two haplotypes were constructed. Therefore, haplotype analyses were not pursued any further.
In order to explore the association of these polymorphisms in the LXRa gene with the plasma lipoprotein/lipid profile, their characteristics were compared between genotype groups (Table 3 ). Owing to their low number, homozygotes for the rare alleles (-115A, -840A, -1830C; n 19), were combined with heterozygotes (n 168) in the analyses. Analyses were performed combining results from men and women as there was no sex £ genotype interaction for each variable tested (data not shown). We found that plasma total cholesterol concentrations were higher in carriers of the -115A allele than in -115G/G homozygotes after adjusting for age and sex (P¼0·05 ; Table 3 . The results remained unchanged after adjusting for age, sex and BMI. When age, sex and BMI were included in the model, we observed a significant increase in the triacylglycerol level in carriers of the -115A allele compared with -115G/G homozygotes. Similar associations were found for the LXRa-840C . A and -1830T . C polymorphisms. We also observed similar trends when homozygotes for the rare allele and heterozygotes were analysed separately (data not shown).
As cholesterol metabolites are potent ligands of LXRa, we examined whether polymorphisms in the LXRa gene could modulate the association between dietary cholesterol intake and plasma lipoprotein/lipid profile. Age-adjusted Pearson correlation coefficients were calculated. In the whole group, cholesterol intake was negatively correlated with plasma HDL-cholesterol concentration (r ¼ 20·16, P¼0·005) but was not correlated with the total cholesterol:HDL-cholesterol ratio or plasma triacylglycerol, apo B, total cholesterol or LDL-cholesterol concentrations (range r ¼ 0·00 to r ¼ 0·10, P¼NS). When these analyses were performed for each genotype group, dietary cholesterol intake was correlated with plasma total cholesterol and LDL-cholesterol concentrations only in carriers of the rare LXRa polymorphisms -115G . A, -840C . A and -1830T . C (range r ¼ 0·28 to r ¼ 0·31, P, 0·05). No correlation with dietary cholesterol was observed in LXRa -115G/G, -840C/C or -1830T/T homozygotes (range r ¼ 20·10 to r ¼ 2 0·08, P¼NS).
The interaction between dietary cholesterol and each polymorphism was therefore tested with plasma total cholesterol and LDL-cholesterol concentrations. In a model including the polymorphism, cholesterol intake, the interaction term (polymorphism £ cholesterol (mg)), age, sex and energy intake, the LXRa-115G . A polymorphism and the interaction explained 1·82 % and 2·90 % of the variance in plasma total cholesterol concentration (Table 4 ). Furthermore, 2·12 % and 2·77 % of the variance in plasma LDL-cholesterol concentration was explained by the polymorphism and the interaction between the LXRa-115G . A polymorphism and dietary cholesterol, respectively. Similar results were obtained for the -840C . A and the -1830T . C polymorphism (Table 4 ). Including saturated fat intake, apo E genotype or BMI in the model did not modify the results.
In order to illustrate these interaction effects, cholesterol intake was separated into two subgroups according to the median value (290·8 mg; Fig. 2 ). We observed that carriers of the -115A allele were characterized by higher plasma total cholesterol and LDLcholesterol concentrations when consuming a diet rich in cholesterol (.290·8 mg). However, in -115G/G homozygotes, plasma total cholesterol and LDL-cholesterol concentrations were similar irrespective of the amount of cholesterol provided from the diet. Similar results were obtained for the effects of the LXRa-840C . A and LXRa-1830T . C polymorphisms on plasma total cholesterol and LDL-cholesterol concentrations (Fig. 2) .
Discussion
In the present study, sixteen genetic variants of the LXRa gene were identified. Among them, three polymorphic sites contained potential binding sites for transcription factors on the common allele. The LXRa-115G . A, -840C . A and -1830T . C polymorphisms were associated with moderate elevation of plasma cholesterol and triacylglycerol levels. Moreover, significant interactions between dietary cholesterol Table 2 . Relative allele frequency of liver X receptor-a gene variants
Gene variants
Rare allele frequency (%)
Single nucleotide polymorphism s without 'rs' numbers were newly identified.
-4077 A>G  -2351 A>G  -2266 C>T  -1851 C>T  -1830 T>C  -1672 C>T  -1003 G>A  -840 C>A  -379 T>C  -717 A>G  -115 G>A  -6 G>A  232+250 T>C  297 T>C  888+138 A>G   5'   1  2  3  4  5  6  7  8  9  1 0 intake and the -115G . A, -840C . A and -1830T . C polymorphisms on plasma total cholesterol and LDL-cholesterol concentrations were observed, suggesting that the association between dietary cholesterol and the plasma lipoprotein/lipid profile was influenced by LXRa gene variants.
To our knowledge, the present study is the first to identify molecular variants in the gene encoding LXRa. Of the newly identified single nucleotide polymorphisms, three were located in regions where transcription factors recognized these sequences to regulate the transcription of LXRa. These sites seem to be abolished when the common allele is substituted for the rare allele at positions -115, -840 and -1830 on the LXRa sequence, suggesting a potential functional role for these genetic variants. In addition, all three polymorphisms are located in well-conserved regions in the mouse LXRa gene. Laffitte et al. (2001) have also shown that the promoter region of the human LXRa gene is similar to the mouse LXRa promoter region, suggesting that regions containing these variants are conserved between species and might thus be important in regulating the transcription of LXRa. Functional analyses must, however, be performed to test the functional significance of these three polymorphisms.
Several studies have demonstrated that LXRa is a key regulator of hepatic cholesterol metabolism. Hepatic cholesterol concentrations were increased 15-20-fold in LXRa 2/2 mice fed a high-cholesterol diet compared with wild-type mice on a similar diet (Peet et al. 1998 ). In addition, mice lacking the LXRa gene did not express the cholesterol 7a-hydroxylase gene, the rate-limiting enzyme in bile acid synthesis normally induced by LXRa (Peet et al. 1998 ), suggesting that LXRa acts as a cholesterol sensor to activate the cholesterol catabolism pathway. In the present study, the plasma lipoprotein/lipid profile was moderately modulated by the presence of molecular variants of the LXRa gene. LXRa also regulates the transcription of genes involved in fatty acid metabolism such as SREBP-1c and FAS, and has been demonstrated to play a role in triacylglycerol metabolism (Peet et al. 1998; Jakel et al. 2004 ). According to data obtained in the present study, variants within the LXRa gene promote the accumulation of plasma triacylglycerol, a finding that contrasts with previous results showing that LXRa activation induces lipogenesis. A possible interaction of LXRa with other genes or with dietary fat intake might explain this apparent contradiction as fatty acids induce the expression of LXRa (Tobin et al. 2000) . Further studies are needed to confirm these results and to understand the effect of LXRa gene variants on plasma triacylglycerol levels.
Interest in studying the interaction between LXRa polymorphisms and dietary cholesterol intake is motivated by the high binding affinity of oxysterols for LXRa (Janowski et al. 1996; Lehmann et al. 1997) . Some of the rate-limiting steps of important pathways in cholesterol metabolism are potent activators of LXRa (Janowski et al. 1996) . As shown by Peet et al. (1998) , mice lacking the LXRa gene (LXRa 2/2 ) were identical to wild-type mice when fed a standard chow diet. However, the hepatic and plasma cholesterol of LXRa 2/2 mice fed a diet rich in cholesterol increased dramatically (Peet et al. 1998) owing to decreased transcription of the gene encoding the rate-limiting enzyme in bile synthesis, cholesterol 7a-hydroxylase. According to results obtained in the present study and by Peet et al. (1998) , we hypothesized that the impact of a change in LXRa transcriptional activity (owing to genetic variants) would be relatively small in a 'normal-cholesterol' environment. In the presence of excess of cholesterol from the diet, however, LXRa is not able to handle this surplus, leading to an increase in plasma total cholesterol and LDLcholesterol concentrations. We could not rely on the absence of induction of cholesterol 7a-hydroxylase, as was seen by Peet et al. (1998) , to explain our results since cholesterol 7a-hydroxylase is not regulated by LXRa in human subjects (Menke et al. 2002; Chiang et al. 2001) . Considering the large number of genes involved in cholesterol metabolism that are regulated by LXRa, genetic variants affecting the transcriptional regulation of LXRa could still have an impact on the plasma lipid profile in the presence of a diet rich in cholesterol.
The impact of plasma total cholesterol and LDL-cholesterol concentrations on the risk of CVD is well established (Wilson et al. 1980; Grundy, 1995) . Several strategies have been proposed to manage cholesterol concentration. Among non-pharmacological strategies, a reduction in dietary cholesterol intake appears to be associated with a decreased risk of CVD (Turpeinen, 1979; Dayton et al. 1968) . A meta-analysis of well-controlled studies confirmed that a diet rich in cholesterol is associated with elevated plasma LDL-cholesterol concentrations (Clarke et al. 1997; Hopkins, 1992) . However, the plasma cholesterol response to a change in cholesterol intake is highly variable and may be the result of polymorphisms in genes involved in cholesterol metabolism, such as LXRa. An identification of these genetic factors could help us to understand why studies examining the relationship between cholesterol intake and plasma cholesterol concentration are not always consistent. In the present study, we observed that three genetic variants in the LXRa gene modulated the relationship between cholesterol intake and plasma lipoprotein/lipid profile.
Other polymorphisms of genes involved in cholesterol metabolism have been shown to modulate the plasma lipid profile response to cholesterol intake. Among these, it is now well demonstrated that subjects with the apo E4 allele show a greater plasma cholesterol responsiveness to changes in cholesterol intake (Sarkkinen et al. 1998 ). In the present study, an interaction between dietary cholesterol and polymorphisms in the gene encoding LXRa was observed independently of the apo E genotype. In addition to cholesterol intake, physical activity could interact with genes involved in lipid metabolism to modulate total cholesterol and LDL-cholesterol concentrations (Boer et al. 1999; Taimela et al. 1996) . Physical activity was not assessed in this study, but the level of physical activity as reported by Bruce and Katzmarzyk (2002) was relatively low. Indeed, 77 % of women and 74 % of men were physically inactive in Canada (Bruce & Katzmarzyk, 2002) .
Nutritional intervention studies will be needed to confirm the role of LXRa as a modulator of the plasma cholesterol response to cholesterol intake. A randomized and cross-over intervention study allows factors such as food intake to be controlled for. In the present study, cholesterol intake was self-reported and might lead to selective underreporting/ overreporting. However, the food-frequency questionnaire has been widely used in epidemiological studies and represents a rapid and inexpensive tool for evaluating nutrient intake in large population studies (Willett et al. 1987) . The presence of other environmental factors such as cigarette smoking might have influenced the observed effects. Statistical adjustment for this covariate did not attenuate the statistical significance of the gene -diet interaction effect (data not shown). Population admixture has been suggested to influence genetic association studies. In the present study, however, subjects were all of French-Canadian descent and population admixture is unlikely to account for the observed effect. Finally, we cannot rule out the possibility that an epistasis effect, not yet identified, might have influenced the effect of the gene -diet interaction.
In conclusion, the results of the present study suggest for the first time an association between human LXRa gene variations and plasma cholesterol concentrations in the presence of a diet rich in cholesterol. The identification of genetic variants of the LXRa gene provides helpful tools for further examining the role of LXRa in terms of the plasma lipoprotein/lipid profile. Although these results need confirmation in other studies, they underline the importance of gene -diet interaction effects in the aetiology of CVD. 
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